BIOMAT Database Logo BIOMAT Database Logo

[Use of adrenergic beta receptor blockaders in myocardial infarct]. 1980

H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011217 Practolol A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS. Dalzic,Eralzdin Practolol,ICI-50172,ICI 50172,ICI50172,Practolol, Eralzdin
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Beta receptor blockaders in acute myocardial infarct].
February 1982, Deutsche medizinische Wochenschrift (1946),
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Combined use of nitrates and beta-adrenergic blockaders in patients with acute myocardial infarct].
April 1985, Kardiologiia,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Use of adrenergic beta blockaders after myocardial infarction].
February 1983, Arquivos brasileiros de cardiologia,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Use of adrenergic beta receptor blockaders in gastroenterology].
January 1988, Klinicheskaia meditsina,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[beta adrenergic receptor blockaders].
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Adrenergic beta receptor blockaders].
February 1975, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Beta-adrenergic receptor blockaders].
March 1969, Terapevticheskii arkhiv,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Beta blockaders in acute myocardial infarct].
January 1978, Cardiology,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Use of adrenergic beta receptor blockaders in labor induction].
July 1972, Ginekologia polska,
H Florkiewicz, and B Rymar, and J Przegaliński, and M Markiewicz
[Use of adrenergic alpha receptor blockaders in patients with myocardial infarct in the state of shock].
September 1970, Kardiologiia,
Copied contents to your clipboard!